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The aim of this study was to elucidate protein-protein interactions between tegument proteins of herpes
simplex virus type 1 (HSV-1). To do so, we have cloned and expressed in the LexA yeast (Saccharomyces
cerevisiae) two-hybrid system, 13 of the 21 currently known tegument proteins of HSV-1. These included the
tegument proteins essential for replication in cell lines, UL17, UL36, UL37, UL48, and UL49, and the
nonessential tegument proteins US11, UL11, UL14, UL16, UL21, UL41, UL46, and UL47. A total of 104
combinations were screened in the yeast two-hybrid assay, with 9 interactions identified. These included:
UL11-UL16, UL36-UL37, UL36-UL48, UL46-UL48, UL47-UL48, and UL48-UL49. The remaining interactions
consisted of self-associations that were observed for US11, UL37, and UL49. The interactions UL36-UL37,
UL36-UL48, UL37-UL37, UL46-UL48, and UL47-UL48 have not been previously reported for HSV-1. The
interaction of UL46-UL48 was verified using an in vitro pull-down assay. The interactions of UL36-UL37 and
UL37-UL37 were verified with a coimmunoprecipitation assay. Knowledge of HSV-1 tegument protein-protein
interactions will provide insights into the pathways of tegument assembly, and the identified interactions are
potential targets for new antiviral drugs.
The herpes simplex virion has four components: an electron-
dense core containing the double-stranded DNA genome (152
kb), the capsid, the tegument, and an outer envelope contain-
ing glycoprotein (33). The icosadeltahedral capsid encloses the
DNA core and consists of 162 capsomeres, 7 different viral
proteins (VPs), VP5 (UL19), VP19C (UL38), VP21 (UL26),
VP22a (UL26.5), VP23 (UL18), VP24 (UL26), and VP26
(UL35), and the products of the UL6 and UL25 genes (33, 44).
VP5 is the major protein and, together with VP19C, VP23, and
VP26, is present on the surface. The surrounding tegument
contains about 20 proteins, including VP1/2 (UL36), VP11/12
(UL46), VP13/14 (UL47), VP16 (UL48), VP22 (UL49), ICP0,
ICP4, and the virion host shutoff protein (UL41) plus the
products of genes US2, US3, US10, US11, UL11, UL13, UL14,
UL16, UL17, UL21, UL37, UL51, and UL56 (18, 28, 29). The
envelope contains at least 8 of the 11 different glycoproteins:
gB, gC, gD, gE, gG, gH, gI, gJ, gK, gL, and gM (33).
The structure of the capsid has been well defined by cryo-
electron microscopy (cryo-EM) after assembly in vitro (43, 44).
In addition, interactions between capsid proteins have been
determined by yeast (Saccharomyces cerevisiae) two-hybrid
analysis (1). In contrast, the structure of the herpes simplex
virus type 1 (HSV-1) tegument is largely unknown. There are
at least 20 proteins within the tegument. Clues to the structure
of tegument have come from a number of studies. By cryo-EM,
UL36 is present in the deepest layers of the tegument attached
to the vertices of the capsid (42) and interacts with the capsid
protein VP5 (27). Recently the use of cryoelectron tomography
has revealed the tegument as frequently forming an asymmet-
ric cap between the capsid and outer envelope (16). The iden-
tification of cytoplasmic HSV “light particles” (26), which con-
sist of the authentic viral membrane with a full complement of
embedded glycoproteins and subjacent tegument, indicates
that most of the tegument and glycoprotein can self-assemble
within the cytoplasm (37). Most of the tegument proteins are
present in HSV-1 light particles, including UL36 (37) and
UL37 (25). In contrast, UL36 and UL37 are not required for
the assembly of pseudorabies virus (PRV; a closely related
alphaherpesvirus) light particles (11). Evidence for UL48 in
both the inner and outer tegument layers has come from de-
tergent solubilization/salt extractions of purified virions (35,
40). Recently, UL48 has been shown to interact with the cyto-
plasmic tail of glycoprotein gH (15). In PRV, there is evidence
for UL49 interacting with glycoproteins E/I and M (13) and for
UL36 interacting with UL37 (20, 21), suggesting superficial
and deep positions within the tegument, respectively. Studies
with PRV mutants suggest that UL37, UL46, UL47, and UL48
are important structural components of the tegument (11, 12,
21, 23, 28, 29). Those tegument proteins that are present in
high amounts (1,000 to 2,000 copies per virion), such as UL46,
UL47, UL48, and UL49, are likely to play a structural role (17,
40). Proteins such as ICP0 and ICP4, which are relatively low
in abundance (100 to 150 copies per virion), probably perform
purely regulatory roles and are carried in the tegument rather
than being structural (39). From previous individual reports,
the following interactions between HSV tegument proteins
have been identified: UL48 and UL49 (10), UL41 and UL48
(34, 36), ICP0 and ICP4 (39), and UL11 and UL16 (24).
In this study, we have defined a number of interactions
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among the tegument proteins of HSV-1 using a yeast two-
hybrid approach. We have confirmed a number of the identi-
fied interactions by expression of individual tegument proteins
in bacterial or mammalian cells.
MATERIALS AND METHODS
Expression constructs. The cloning of HSV-1 tegument genes into the yeast
two-hybrid vectors displayBait and displayTarget (Display Systems Biotech) has
been previously described (9). Additional tegument genes cloned in the present
study included UL11, UL14, UL16, UL21, and UL49. UL36 fragments corre-
sponding to amino acids 124 to 511, 512 to 767, and 1 to 767 were amplified from
displayBait/UL36(1–1874) (9) and inserted into EcoRI/XhoI-digested display-
Bait or EcoRI-digested displayTarget. For bacterial expression, the UL46 gene
was excised from displayBait and inserted into EcoRI-digested pGEX-5X-1
(Amersham). Cloning of UL48 into pET28a (Novagen) to generate an expres-
sion plasmid which encodes untagged UL48 has been previously described (7).
For expression in mammalian cells, the UL36 fragment corresponding to amino
acids 512 to 767 and UL37 were inserted into EcoRI/XhoI- or EcoRI-digested
pCMV-HA and/or pCMV-myc (Clontech) (both vectors were modified so that
the EcoRI site was in the same reading frame as displayBait and displayTarget).
Human kinesin KIF5B fragment 814 to 963 was obtained from a displayBait
construct (5) and inserted into EcoRI/XhoI-digested pCMV-HA and pCMV-
myc.
Yeast two-hybrid assay. The use of the LexA-based yeast two-hybrid assay to
determine protein-protein interactions has been previously described (5). The
protocols for qualitative assessment of protein-protein interactions, quantifica-
tion of each positive interaction using a -galactosidase assay, and determination
of protein expression in yeast were as described previously (5).
In vitro pull-down assay. The glutathione S-transferase (GST)-tagged UL46
and untagged UL48 constructs were expressed and harvested as previously de-
scribed (7). Conditions for binding, wash, and elution were as previously de-
scribed (5). GST fusion proteins were immobilized on glutathione-Sepharose
beads prior to incubation with either HSV-1-infected Hep-2 cell lysates, pre-
pared as previously described (7), or bacterial lysates containing untagged UL48.
Coimmunoprecipitation assay. HeLa cells were grown at 37°C (5% CO2) in
Dulbecco’s modified Eagle medium supplemented with 10% (vol/vol) fetal calf
serum (JRH Bioscience), 100 U/ml penicillin, and 100 g/ml streptomycin
(Sigma). HeLa cells were grown to 80% confluence in six-well plates and were
transiently transfected using GeneJuice transfection reagent (Novagen). Cells
were harvested at 48 h posttransfection and lysed in M-PER buffer (Pierce)
containing mammalian protease inhibitors (Sigma). Lysates were processed with
the Profound mammalian c-myc tag coimmunoprecipitation kit (Pierce) accord-
ing to the manufacturer’s instructions. Protein complexes were eluted by heating
in 2 nonreducing sample buffer (Pierce).
Analysis of protein complexes. Proteins were separated by sodium dodecyl
sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and, for analysis of
expression in yeast or for in vitro pull-downs, were processed by immunoblotting
as previously described (6). For coimmunoprecipitation experiments, immuno-
blots were washed with phosphate-buffered saline (PBS) before incubatoin for
1 h with Odyssey blocking buffer (Licor-Biosciences). Blots were then incubated
for 1 h with primary antibody diluted in Odyssey blocking buffer containing 0.1%
(vol/vol) Tween 20. Blots were then washed four times for 5 min with PBS
containing 0.1% (vol/vol) Tween 20 before incubation for 1 h with secondary
antibody diluted as described above. Blots were then washed as described above
before being rinsed and stored protected from light in PBS. Detection was
performed with an Odyssey infrared imaging system (Licor-Biosciences). The
primary antibodies used included mouse monoclonal and rabbit polyclonal an-
tibodies against hemagglutinin (HA), mouse monoclonal antibodies against
LexA and UL48 (all from Santa Cruz Biotechnology), rabbit polyclonal antibody
against HSV-1 (Dako), and mouse monoclonal against c-myc (Clontech). Sec-
ondary antibodies for the Odyssey system, both used at a 1:2,000 dilution,
included goat anti-mouse Alexa Fluor 680-conjugated immunoglobulin G (IgG;
Molecular Probes) and goat anti-rabbit IRdye800-conjugated IgG (Rockland,
Inc.).
RESULTS
Yeast two-hybrid analysis of the interaction of HSV-1 tegu-
ment proteins. In this study, we have cloned and expressed, in
the LexA yeast two-hybrid system, 13 of the 21 known tegu-
ment proteins of HSV-1 (29). Those cloned and expressed
include US11, UL11, UL14, UL16, UL17, UL21, UL36, UL37,
UL41, UL46, UL47, UL48, and UL49. All genes cloned were
full-length constructs except UL36, which was cloned in the
bait vector as a fragment corresponding to acids 1 to 1874 (9)
and in the target vector as a fragment corresponding to amino
acids 1 to 767. A matrix approach, testing 104 combinations in
the yeast two-hybrid assay was then undertaken. Combinations
involving bait constructs of UL14, UL16, UL17, or UL48 could
not be assessed due to autoactivation observed when tested
against target vector containing no insert (not shown). A qual-
itative plate-based assay was used to initially identify positive
interactions. This assay identifies positive interactions through
expression of the reporter genes LEU2 and lacZ. This yielded
9 positive interactions that included US11-US11, UL11-UL16,
UL36-UL37, UL36-UL48, UL37-UL37, UL46-UL48, UL47-
UL48, UL48-UL49, and UL49-UL49 (Fig. 1A). Quantitative
-galactosidase activity values were then obtained for each
positive interaction using a liquid assay (Fig. 1B). Only in the
case of UL47-UL48 was there a lack of -galactosidase activity
above the background (Fig. 1B). Whether this particular inter-
action is a true positive in the Y2H assay, therefore, requires
further investigation. The expression of each construct used in
the yeast two-hybrid assay was confirmed by immunoblotting
(not shown) using antibodies against the LexA fusion tag (bait
constructs) and the HA fusion tag (Target constructs).
Of the 9 identified interactions, only that of UL36-UL37
could be tested and confirmed in both orientations in the yeast
two-hybrid assay. The other interactions were either self-asso-
ciations or involved one partner which autoactivates when in-
serted in the bait vector, e.g., UL16 and UL48 (Fig. 1A). Four
of the interactions have been previously identified in HSV-1
using other assays. The self-association of HSV-1 tegument
protein US11 has previously been demonstrated (4). Interac-
tion of HSV-1 tegument protein UL11 with UL16 using an in
vitro pull-down assay has recently been reported (24). The
self-association of UL49 and interaction with UL48 has also
been previously reported (10).
The remaining 5 interactions, UL36-UL37, UL36-UL48,
UL37-UL37, UL46-UL48, and UL47-UL48, have not been
documented previously for HSV-1. In the case of UL36-UL37,
the interaction has been reported using homologous PRV teg-
ument proteins and the LexA yeast two-hybrid assay (20). It
should be noted that both HSV-1 UL36 fragments 1 to 1874
and 1 to 767 used in this study contain the region (amino acids
453 to 608) which is homologous to the UL37-interacting re-
gion identified in PRV UL36 (20). The additional UL36 frag-
ments 124 to 511 and 512 to 767 were also tested for UL37
binding (Fig. 2). The fact that UL36 fragment 512 to 767 is
strongly positive for UL37 binding implies that the minimal
UL37-binding site in HSV-1 UL36 corresponds to this region
(Fig. 2).
The interaction of tegument proteins UL46 and UL48 has
been suggested from colocalization and copurification studies
with HSV-2 (19). Modulation of HSV-1 UL48 transcriptional
activity by both UL46 and UL47 supports a direct interaction
(40). No report to date has documented the self-association of
UL37 in any alphaherpesviruses.
The known interaction of UL41 with UL48, which was pre-
viously demonstrated using the GAL4 yeast two-hybrid assay
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(36), could not be reproduced in the LexA yeast two-hybrid
assay (Fig. 1A). One of the reasons for this may be the differ-
ence between the two yeast systems with respect to the DNA-
binding and activation domain fusion partners, each of which
would have differing effects on the correct folding of the re-
spective fused viral protein. Reversing the LexA bait and target
fusion partners was not possible, since UL48 strongly autoac-
tivates in bait. A recently reported interaction between UL16
and UL21 in PRV (22) could not be confirmed for HSV-1, as
both autoactivate in the yeast two-hybrid assay (Fig. 1A).
Nevertheless, we have been able to reproduce four previ-
ously observed interactions for HSV-1 tegument proteins. This
strongly supports the chosen LexA yeast two-hybrid assay as a
valid system for determining binary interactions between
HSV-1 structural proteins. Five new interactions were also
identified with this screen.
In vitro pull-down assay. To further validate the yeast two-
hybrid approach, lysates from HSV-infected mammalian cells
were added to GST-UL46. There was evidence not only of the
expected pairwise interaction (UL46-UL48) but also of appar-
ent secondary interactions with other viral proteins (not
shown). Whether the two viral proteins are interacting directly
or through an intermediate viral protein was unclear. There-
fore, an approach based on expression of individual viral pro-
teins was subsequently used to confirm interactions.
The same in vitro pull-down assay using bacterially ex-
pressed viral proteins was employed. The interaction between
UL46 and UL48 was confirmed using this assay. Recombinant
untagged UL48, in the absence of other viral proteins, bound
only to GST-UL46 and not to GST (Fig. 3A). The presence of
GST fusion proteins was also confirmed (Fig. 3B). Attempts to
verify some of the other interactions with this assay were un-
successful due to poor expression and/or low solubility of viral
proteins such as UL36 and UL37 (not shown).
Coimmunoprecipitation assay. An alternative coimmuno-
precipitation assay was subsequently employed to validate the
yeast two-hybrid interactions. Two of the five new HSV-1 in-
teractions (UL36-UL37 and UL37-UL37) identified from the
yeast two-hybrid screen were chosen. A fragment of UL36
corresponding to amino acids 512 to 767 was expressed with a
myc tag and found to interact with full-length HA-tagged UL37
(Fig. 4). UL36 fragment 512 to 767 was previously confirmed to
FIG. 1. Yeast two-hybrid analysis of the interaction of HSV-1 teg-
ument proteins. (A) Summary of data obtained with yeast cotrans-
formed with various combinations of bait and target fusion constructs.
Interactions were initially assessed using a qualitative in vivo plate
assay (at day 3), with readout being expression of the reporter genes
LEU2 and lacZ. Positive interactions (shaded) were observed as blue
colonies, with  indicating the lightest blue and  indicating the
darkest blue. No growth () indicates a negative interaction. Autoac-
tivation (AA) was observed for a number of bait constructs. (B) Sum-
mary of quantitative liquid -galactosidase assay. The activity was
calculated from the following equation: -galactosidase activity 
1,000  A420/(t  V  OD660), where t is time (in minutes) of incu-
bation, V is volume of cells (in ml) used in the assay, and OD660 is the
optical density at 660 nm. The values obtained for -galactosidase
activity are the averages of measurements from at least three separate
colonies. Negative controls consisted of displayBait/viral gene insert
and displayTarget/no insert. UL36 in displayBait encodes amino acids
1 to 1874, while UL36 in displayTarget encodes amino acids 1 to 767.
FIG. 2. Yeast two-hybrid analysis of the interaction of UL36 and
UL37. (A) Summary of full-length UL37 binding to fragments of
UL36. The region 453 to 608, which is homologous to the previously
determined UL37-binding site in PRV, is indicated (20). (B) Summary
of quantitative liquid -galactosidase assay for UL36 fragments 124 to
511 and 512 to 767. The activity was calculated from the following
equation: -galactosidase activity  1,000  A420/(t  V  OD660),
where t is time (in minutes) of incubation, V is the volume of cells (in
ml) used in the assay, and OD660 is the optical density at 660 nm. The
values obtained for -galactosidase activity are the averages of mea-
surements from at least three separate colonies. X-gal, 5-bromo-4-
chloro-3-indolyl--D-galactopyranoside; , no growth or color change
at day 3; , darkest blue colonies at day 3.
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interact with UL37 in the yeast two-hybrid assay (Fig. 2). Full-
length myc-tagged UL37 was found to interact with full-length
HA-tagged UL37 (Fig. 4). No significant binding of UL36 or
UL37 was observed with either myc- or HA-tagged kinesin
KIF5B, confirming the specificity of the coimmunoprecipita-
tion assay (Fig. 4).
Therefore, 7 of the 9 novel interactions identified by the
yeast two-hybrid screen have been confirmed by other assays, 3
in this study and 4 previously.
DISCUSSION
It has become widely accepted that the majority of the teg-
ument is added to the capsid of HSV-1 in the cytoplasm (28–
30). Capsids are first assembled in the nucleus before they
traverse the inner and outer nuclear membrane in a primary
envelopment and de-envelopment step. In nonneuronal cells,
assembly is completed by secondary envelopment at the trans-
Golgi compartment. In this assembly process, inner tegument
proteins are added first to the capsid. Outer tegument proteins
preassemble and interact with the cytoplasmic tails of viral
glycoproteins at the Golgi. During secondary envelopment,
inner tegument-coated capsid then links with outer tegument-
glycoprotein to form the final viral particle, which is released
by exocytosis (28, 29).
In this study, we have identified a number of binary inter-
actions involving HSV-1 tegument proteins (Fig. 1). Whether
these interactions are structural, regulatory, or other requires
further elucidation. However, from the work of others and the
FIG. 4. Coimmunoprecipitation assay. HeLa cells were cotrans-
fected with expression plasmids encoding myc-tagged and HA-tagged
proteins. Cells lysates were harvested at 48 h posttransfection and
immunoprecipitated (IP) with mouse anti-myc monoclonal antibody.
Protein complexes were separated by SDS-PAGE (4 to 20%). (A) Im-
munoblotting with mouse anti-myc monoclonal antibody; (B) immu-
noblotting with rabbit anti-HA polyclonal antibody. The positions of
UL36, UL37, and KIF5B along with coeluting mouse anti-myc IgG
heavy and light chains detected by the secondary anti-mouse conjugate
used during immunoblotting are indicated. The predicted masses of
various protein products are as follows: UL36 512 to 767, 30 kDa;
UL37, 120 kDa; KIF5B 814 to 963, 19 kDa.
FIG. 3. In vitro pull-down assay to assess the interaction of UL46
and UL48. Bacterial lysates containing recombinant untagged UL48
were added to GST or GST-UL46 on glutathione-Sepharose beads.
Protein complexes were subsequently eluted and separated by SDS-
PAGE (4 to 20%). (A) Immunoblotting with anti-UL48 confirms the
presence of recombinant untagged UL48 coeluting preferentially with
GST-UL46 in the absence of other viral proteins. (B) Coomassie blue
staining to confirm the presence of GST proteins eluted from gluta-
thione-Sepharose beads. The predicted masses of various protein
products are as follows: GST, 26 kDa; GST-UL46, 104 kDa; untagged
UL48, 54 kDa.
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present model for viral assembly, a number of the observed
interactions are likely to be important for assembly. First, the
interaction of UL36 and UL37 appears to have a definite
structural role. The absence of either protein in HSV-1 or
PRV significantly impairs or blocks further addition of tegu-
ment and subsequent viral maturation (2, 3, 20, 21). This fits
with their apparent location in the virion, i.e., inner tegument
adjacent to the capsid. UL36 has been shown to interact with
the major capsid protein VP5 (product of UL19 gene) (27)
and, by cryo-EM, appears to form the inner tegument layer
(42). UL37 then interacts with VP5-bound UL36 to complete
the inner tegument layer (20). In the case of PRV, a recent
study shows that deletion of the UL37 binding site in UL36
does not abolish secondary envelopment (14). This suggests
that the interaction, though important, is not essential for
virion assembly. Whether the same applies to HSV-1 requires
further investigation. Certainly this supports the existence of
other links between the inner and outer tegument. One of
these links may be provided by the interaction of UL36 and
UL48 observed in this study. In support of this, previous stud-
ies with HSV-1 and PRV lacking UL48 suggest that it is im-
portant for linking capsids coated with UL36 and UL37 to the
outer tegument and envelope (11, 31).
Whether the observed interactions among the outer tegu-
ment proteins (UL46, UL47, UL48, and UL49) have a struc-
tural role in HSV-1 assembly also requires further investiga-
tion. Certainly, deletion of either UL46 or UL47 in HSV-1 and
PRV does not block viral assembly (23, 41), although deletion
of UL47 does impair secondary envelopment in PRV (23). In
fact, deletion of all the major tegument proteins, UL46, UL47,
UL48, and UL49, in PRV (12) can be tolerated, supporting
redundancy in tegument assembly. In the case of PRV, dele-
tion of either UL46, UL47, or UL48 does not prevent incor-
poration of the remaining two proteins into the tegument,
although deletion of UL47 may reduce the incorporation of
UL48 into the tegument (11, 23). In HSV-1, deletion of UL47
leads to increased levels of incorporation of UL46 into virions,
which also supports structural redundancy (40). Deletion of
UL49 in HSV-1 also does not have a significant effect on viral
assembly (32). Previous studies of HSV-1 have suggested that
both UL46 and UL47 have a role in enhancing UL48-induced
immediate-early viral gene expression (19, 40, 41). Nuclear
localization has been demonstrated for UL47 (8, 30), support-
ing a role in regulation of UL48 activity. Using green fluores-
cent protein fusion proteins, UL46 was only found in the cy-
toplasm (38), arguing against a role for regulation of UL48
activity in the whole cell. However, lack of nuclear localization
needs to be confirmed by other techniques.
A number of interactions have been demonstrated between
tegument proteins and either membrane-associated tegument
protein(s) or the cytoplasmic tails of viral glycoproteins. These
include the interaction of UL16 with the membrane associat-
ed-tegument protein UL11 (24), which was confirmed in this
study, UL49 with gE and gM (13), and UL48 with gH (15).
Like the interactions between outer tegument proteins, there is
some redundancy but each appears to play a role in secondary
envelopment at the Golgi (28, 29).
A number of self-associations were also identified in this
study. These involved the tegument proteins US11, UL37, and
UL49 (Fig. 1). Whether the self-associations are simply dimers
or higher-order oligomers requires further investigation. In the
case of US11, higher-order oligomers have been previously
demonstrated and may be important for the nonstructural
functions of US11 (4). Recent work indicates that the tegu-
ment contains thin filaments, and it is possible that they are
formed from the polymerization of tegument proteins (16).
In conclusion, we have identified a number of novel inter-
actions among the tegument proteins of HSV-1. A number
involve the essential tegument proteins UL36, UL37, and
UL48. Further elucidation of the role of these interactions in
viral assembly could form the basis for novel antiviral targets.
The approach undertaken in this study now provides a signif-
icant platform for further biochemical and biological studies
on viral assembly. Future studies will involve construction of
viral mutants with appropriate mutations and/or deletions
within individual tegument genes to study resulting effects on
assembly.
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